InvestorsHub Logo
Followers 41
Posts 1440
Boards Moderated 0
Alias Born 04/05/2009

Re: biotech2010 post# 3017

Saturday, 04/08/2017 10:16:20 PM

Saturday, April 08, 2017 10:16:20 PM

Post# of 3833
The fact that he talked so specifically about partnerships means that something is cooking you have to read between the lines. That is exactly what these other investors are doing. You are trying to impugn his credibility and I'm all for it but if you are going to do that look at his track record.

He is absolutely so far right conservative he's actually left. So if you actually believe what he is saying I have to chuckle. After the Psoriasis trial where he said they missed their endpoint when they had only 4 out of 10 people dosed he was wrong. How can you miss an endpoint when you have 40% of the data that was over 50%. How did he know the other 60% wasnt going to be at 100% thereby meeting their endpoint.

When he failed to meet endpoints in the FX trial when there wasn't ONE approvable endpoint being measured. He as dead wrong saying anything about endpoints. It was about measuring devices. You cant fail to meet an endpoint when your not even measuring one. That FX trial was a failure to design a trial not a failure of the medicine. What deluded person thought they could move imaging that takes 20 years to develop in 4 months! See the point he underdelivers so much which is why the company stock WAS in the toilet. Now with all the articles, upgrade, the money, renewed interest, and a better understanding of how they are THE NUMBER #1 leader in advanced NASH does anyone believe this is still a secret? The guy might not be able to sell, might be a lousy leader but when you are sitting on such a big gold mine people are going to seek you out. That is a FACT. So do I think you should take his words at face value? H-LL NO! Have to read between the lines.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News